Related Experiment Video
Updated: Mar 26, 2026

06:29
Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
11.3K
Wilms tumor with intravascular tumor thrombus
1Department of Pediatric Hematology Oncology, Ankara Children's Hematology Oncology Training and Research Hospital, Altındağ, Ankara, Turkey.
Translational Pediatrics
|February 3, 2016
Summary
Wilms tumor (WT) can extend into blood vessels, forming tumor thrombi. Preoperative chemotherapy is recommended to shrink these thrombi, aiding surgical removal and improving outcomes for pediatric patients.
Area of Science:
- Pediatric Oncology
- Pediatric Surgery
- Vascular Surgery
Background:
- Wilms tumor (WT) is a common pediatric solid tumor with a tendency for vascular invasion.
- Tumor thrombus formation in the renal vein, inferior vena cava, and right atrium occurs in a significant percentage of WT cases.
- Vascular invasion in WT is often asymptomatic and detected via imaging.
Purpose of the Study:
- To review the incidence, diagnosis, and management of Wilms tumor with vascular thrombus.
- To highlight the role of neoadjuvant chemotherapy in managing WT-associated tumor thrombi.
- To emphasize the importance of a multidisciplinary approach for these complex cases.
Main Methods:
- Review of imaging modalities (CT, MRI, Doppler USG) for detecting intravascular tumor thrombus.
- Analysis of treatment strategies, including preoperative chemotherapy and surgical intervention.
- Discussion of factors influencing management decisions, such as thrombus extent and chemotherapy response.
Main Results:
- Doppler USG, CT, and MRI are effective in diagnosing intravascular tumor thrombi in WT.
- Preoperative chemotherapy is effective in reducing thrombus size in most cases, facilitating surgery.
- Neoadjuvant chemotherapy leads to tumor regression in approximately 50% of patients, often avoiding cardiac bypass.
Conclusions:
- Wilms tumor with vascular thrombus requires a multidisciplinary team approach.
- Preoperative chemotherapy is the recommended initial management for most cases of WT with tumor thrombus.
- Careful case-by-case evaluation is crucial for determining the optimal treatment strategy, balancing surgery and chemotherapy.
More Related Videos
Related Concept Videos
Venous Thrombosis I: Introduction
668
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
668
Venous Thrombosis III: Interprofessional Care
460
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
460
Metastasis
6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K

